Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel M Goldman

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|October 10, 2012
Genetic modification of the association of paraquat and Parkinson's diseaseSamuel M Goldman, Freya Kamel, G Webster Ross, et al.
Parkinsonism & Related Disorders|October 15, 2013
Dietary fat intake, pesticide use, and Parkinson's diseaseFreya Kamel, Samuel M Goldman, David M Umbach, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 23, 2024
Dry-Cleaning Chemicals and a Cluster of Parkinson's Disease and Cancer: A Retrospective InvestigationE Ray Dorsey, Dan Kinel, Meghan E Pawlik, et al.
NPJ Parkinson'S Disease|March 2, 2021
The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonismCaroline M Tanner, Steven R Cummings, Michael A Schwarzschild, et al.
Annals of Neurology|January 26, 2012
Head injury, α-synuclein Rep1, and Parkinson's diseaseSamuel M Goldman, Freya Kamel, G Webster Ross, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 20, 2014
Peptidoglycan recognition protein genes and risk of Parkinson's diseaseSamuel M Goldman, Freya Kamel, G Webster Ross, et al.
Environmental Health Perspectives|January 29, 2011
Rotenone, paraquat, and Parkinson's diseaseCaroline M Tanner, Freya Kamel, G Webster Ross, et al.
Nature Biotechnology|August 10, 2021
Remote smartphone monitoring of Parkinson's disease and individual response to therapyLarsson Omberg, Elias Chaibub Neto, Thanneer M Perumal, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 15, 2020
Nonsteroidal Anti-inflammatory Use and LRRK2 Parkinson's Disease PenetranceMarta San Luciano, Caroline M Tanner, Cheryl Meng, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 11, 2017
Heart rate variability in leucine-rich repeat kinase 2-associated Parkinson's diseaseNaomi P Visanji, Grace S Bhudhikanok, Tiago A Mestre, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Movement Disorders : Official Journal of the Movement Disorder Society|October 10, 2012
Genetic modification of the association of paraquat and Parkinson's diseaseSamuel M Goldman, Freya Kamel, G Webster Ross, et al.
Parkinsonism & Related Disorders|October 15, 2013
Dietary fat intake, pesticide use, and Parkinson's diseaseFreya Kamel, Samuel M Goldman, David M Umbach, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 23, 2024
Dry-Cleaning Chemicals and a Cluster of Parkinson's Disease and Cancer: A Retrospective InvestigationE Ray Dorsey, Dan Kinel, Meghan E Pawlik, et al.
NPJ Parkinson'S Disease|March 2, 2021
The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonismCaroline M Tanner, Steven R Cummings, Michael A Schwarzschild, et al.
Annals of Neurology|January 26, 2012
Head injury, α-synuclein Rep1, and Parkinson's diseaseSamuel M Goldman, Freya Kamel, G Webster Ross, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 20, 2014
Peptidoglycan recognition protein genes and risk of Parkinson's diseaseSamuel M Goldman, Freya Kamel, G Webster Ross, et al.
Environmental Health Perspectives|January 29, 2011
Rotenone, paraquat, and Parkinson's diseaseCaroline M Tanner, Freya Kamel, G Webster Ross, et al.
Nature Biotechnology|August 10, 2021
Remote smartphone monitoring of Parkinson's disease and individual response to therapyLarsson Omberg, Elias Chaibub Neto, Thanneer M Perumal, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 15, 2020
Nonsteroidal Anti-inflammatory Use and LRRK2 Parkinson's Disease PenetranceMarta San Luciano, Caroline M Tanner, Cheryl Meng, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 11, 2017
Heart rate variability in leucine-rich repeat kinase 2-associated Parkinson's diseaseNaomi P Visanji, Grace S Bhudhikanok, Tiago A Mestre, et al.
Pageof 6